Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Heuser

Showing results (181-190 of 280) with videos related to

Pageof 28
Sort By:
Experimental Hematology|May 25, 2016
Epigenetic therapy as a novel approach for GFI136N-associated murine/human AMLLacramioara Botezatu, Lars C Michel, Anne Helness, et al.
Annals of Hematology|May 20, 2019
Lipid nanoparticle-mediated siRNA delivery for safe targeting of human CML in vivoNidhi Jyotsana, Amit Sharma, Anuhar Chaturvedi, et al.
Haematologica|January 13, 2018
Gfi1b: a key player in the genesis and maintenance of acute myeloid leukemia and myelodysplastic syndromeAniththa Thivakaran, Lacramioara Botezatu, Judith M Hönes, et al.
Leukemia|August 1, 2020
Safety and efficacy of BAY1436032 in IDH1-mutant AML: phase I study resultsMichael Heuser, Neil Palmisiano, Ioannis Mantzaris, et al.
Leukemia|January 8, 2025
A novel prognostic risk model for patients with refractory/relapsed acute myeloid leukemia receiving venetoclax plus hypomethylating agentsRabia Shahswar, Razif Gabdoulline, Katja Krueger, et al.
British Journal of Haematology|November 1, 2018
Phase I/II study on cytarabine and idarubicin combined with escalating doses of clofarabine in newly diagnosed patients with acute myeloid leukaemia and high risk for induction failure (AMLSG 17-10 CIARA trial)Jürgen Krauter, Walter Fiedler, Richard F Schlenk, et al.
Blood Advances|July 24, 2025
Long-term results from the AGILE study of azacitidine plus ivosidenib vs placebo in newly diagnosed IDH1-mutated AMLPau Montesinos, Dylan M Marchione, Christian Récher, et al.
Hemasphere|March 11, 2025
Cell-free DNA for detection and monitoring of extramedullary AML relapseHenri C Hupe, Clara P Wienecke, Stephan Bartels, et al.
Cancer Cell|July 15, 2016
RIPK3 Restricts Myeloid Leukemogenesis by Promoting Cell Death and Differentiation of Leukemia Initiating CellsUlrike Höckendorf, Monica Yabal, Tobias Herold, et al.
Blood|January 13, 2012
Spliceosomal gene aberrations are rare, coexist with oncogenic mutations, and are unlikely to exert a driver effect in childhood MDS and JMMLShinsuke Hirabayashi, Christian Flotho, Jessica Moetter, et al.
Pageof 28

Showing results (181-190 of 280) with videos related to

Sort By:
Pageof 28
Experimental Hematology|May 25, 2016
Epigenetic therapy as a novel approach for GFI136N-associated murine/human AMLLacramioara Botezatu, Lars C Michel, Anne Helness, et al.
Annals of Hematology|May 20, 2019
Lipid nanoparticle-mediated siRNA delivery for safe targeting of human CML in vivoNidhi Jyotsana, Amit Sharma, Anuhar Chaturvedi, et al.
Haematologica|January 13, 2018
Gfi1b: a key player in the genesis and maintenance of acute myeloid leukemia and myelodysplastic syndromeAniththa Thivakaran, Lacramioara Botezatu, Judith M Hönes, et al.
Leukemia|August 1, 2020
Safety and efficacy of BAY1436032 in IDH1-mutant AML: phase I study resultsMichael Heuser, Neil Palmisiano, Ioannis Mantzaris, et al.
Leukemia|January 8, 2025
A novel prognostic risk model for patients with refractory/relapsed acute myeloid leukemia receiving venetoclax plus hypomethylating agentsRabia Shahswar, Razif Gabdoulline, Katja Krueger, et al.
British Journal of Haematology|November 1, 2018
Phase I/II study on cytarabine and idarubicin combined with escalating doses of clofarabine in newly diagnosed patients with acute myeloid leukaemia and high risk for induction failure (AMLSG 17-10 CIARA trial)Jürgen Krauter, Walter Fiedler, Richard F Schlenk, et al.
Blood Advances|July 24, 2025
Long-term results from the AGILE study of azacitidine plus ivosidenib vs placebo in newly diagnosed IDH1-mutated AMLPau Montesinos, Dylan M Marchione, Christian Récher, et al.
Hemasphere|March 11, 2025
Cell-free DNA for detection and monitoring of extramedullary AML relapseHenri C Hupe, Clara P Wienecke, Stephan Bartels, et al.
Cancer Cell|July 15, 2016
RIPK3 Restricts Myeloid Leukemogenesis by Promoting Cell Death and Differentiation of Leukemia Initiating CellsUlrike Höckendorf, Monica Yabal, Tobias Herold, et al.
Blood|January 13, 2012
Spliceosomal gene aberrations are rare, coexist with oncogenic mutations, and are unlikely to exert a driver effect in childhood MDS and JMMLShinsuke Hirabayashi, Christian Flotho, Jessica Moetter, et al.
Pageof 28